Skip to main content

Elmind Capital, LP

SEC CIK
0002052213
Latest filing
Aug 14, 2026

COGT holding history

Cogent Biosciences, Inc. in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COGT overviewAll 13F holders of COGTFull Q2 2026 holdings

Shares (Q2 2026)
1,170,740
Value
$45.3M
% of portfolio
11.4%
Quarters held
3
Since Q4 2025
Holdings of COGT by Elmind Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,170,740$45.3M11.4%00.0%UnchangedHolders
Q1 20261,170,740$45.1M12.8%00.0%UnchangedHolders
Q4 20251,170,740$41.6M12.3%–No prior filingHolders